From: Utilization of diagnostic ultrasound and intravenous lipid-encapsulated perfluorocarbons in non-invasive targeted cardiovascular therapeutics
Disease entity
DUS frequency/trigging
Specific gene
Specific application
Diabetes
1:4
DNA-planned
Beta cell regeneration
Limb ischemia
DNA-planned VGE
Angiogenesis
Tumor
DNA
Tumor suppression
1:10
ShRNA
Anti-angiogenesis